This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of various drugs, especially those targeting neurological and psychiatric disorders. Its structure, featuring a fluorophenyl group, makes it valuable for creating molecules with enhanced binding affinity and selectivity towards specific biological targets. Additionally, it is explored in the development of potential treatments for conditions like anxiety, depression, and epilepsy due to its ability to modulate neurotransmitter systems. Its hydrochloride form ensures improved solubility and stability, facilitating its use in formulation studies and preclinical testing.